During primary infection of human dermal microvascular endothelial cells, KSHV rapidly activates Nrf2, primarily through a reactive oxygen species (ROS)-mediated mechanism, leading to the separation of Nrf2 from its inhibitory protein Keap1 and promoting Nrf2 phosphorylation and subsequent nuclear translocation [157]. Here, NFE2L2 is linked to infection.